Medivolve Inc (MEDVD) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Medivolve Inc (MEDVD) stock?
Medivolve Inc (MEDVD) no longer trades on public markets. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Medivolve Inc (MEDVD). Medivolve Inc. is a healthcare company focused on medical instruments and supplies, headquartered in Toronto, US. The company operates in a challenging market environment with limited public information about its recent activities. Sector: Healthcare.
Last analyzed: Jun 14, 2026Analyst Coverage for MEDVD: MEDVD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MEDVD against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
MEDVD: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Medivolve Inc (MEDVD) Healthcare & Pipeline Overview
Medivolve Inc. operates within the healthcare sector, specializing in medical instruments and supplies, while navigating a competitive landscape with a focus on innovation and market adaptation.
What Is the Investment Thesis for MEDVD?
Medivolve Inc. presents a complex investment thesis characterized by significant challenges and potential opportunities. With a profit margin of -2397.5% and a gross margin of 78.3%, the company faces substantial financial hurdles that need to be addressed for sustainable growth. The absence of a dividend yield indicates a focus on reinvestment rather than returning capital to shareholders. Key value drivers for Medivolve include the potential for market expansion in the medical instruments sector, where the demand for innovative healthcare solutions is increasing. However, the company must overcome its current financial difficulties and improve operational efficiency to capitalize on these growth catalysts. The healthcare market is projected to grow, and Medivolve's ability to innovate and adapt will be critical in determining its success over the next few years.
Based on FMP financials and quantitative analysis
MEDVD Key Highlights
Profit margin of -2397.5% indicates significant financial challenges.
- Gross margin of 78.3% reflects potential for profitability if operational issues are resolved.
- No dividend yield suggests a focus on reinvestment for growth.
- Employee count of 95 indicates a small to medium-sized enterprise.
- Headquartered in Toronto, US, positioning the company within a robust healthcare market.
Who Are MEDVD's Competitors?
MEDVD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MDT Medtronic plc | $91.62 | -0.29% | $117B | 795-pillar |
| SYK Stryker Corporation | $268.65 | -0.50% | $103B | 775-pillar |
| ABT Abbott Laboratories | $101.96 | -1.35% | $176B | 695-pillar |
| BSX Boston Scientific Corporation | $42.98 | -0.28% | $63.9B | 815-pillar |
| GE GE Aerospace | $323.61 | -0.17% | $336B | 675-pillar |
| ISRG Intuitive Surgical, Inc. | $368.93 | +2.35% | $130B | 935-pillar |
| BDX Becton, Dickinson and Company | $176.42 | -1.88% | $48.6B | 705-pillar |
| ALC Alcon Inc. | $66.55 | -2.75% | $32.5B | 765-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MEDVD's Key Strengths?
High gross margin potential indicates efficient cost management.
- Small workforce allows for flexibility and rapid decision-making.
- Focus on healthcare innovation aligns with industry trends.
What Are MEDVD's Weaknesses?
Significant negative profit margin presents financial challenges.
- Limited public information may raise investor concerns.
- Small size may limit market reach and scale.
What Could Drive MEDVD Stock Higher?
Potential product launches that could enhance market presence.
- Efforts to improve operational efficiency and financial health.
- Focus on innovation to meet evolving healthcare demands.
What Are the Key Risks for MEDVD?
Regulatory challenges may delay product approvals.
- Financial instability due to negative profit margins.
- Competitive pressures from established players in the market.
What Are the Growth Opportunities for MEDVD?
- Expansion into Telehealth: The telehealth market is projected to grow to $459.8 billion by 2026, driven by increased demand for remote healthcare services. Medivolve can capitalize on this trend by developing medical instruments that facilitate telehealth applications, enhancing patient care and accessibility.
- By focusing on cutting-edge technologies, the company can differentiate itself and capture market share.
- Strategic Partnerships: Collaborating with healthcare providers and technology firms can enhance Medivolve's product offerings. Such partnerships can lead to co-development of new medical instruments, tapping into the growing demand for integrated healthcare solutions.
- Geographic Expansion: Entering emerging markets, particularly in Asia-Pacific, where healthcare spending is increasing, can provide significant growth opportunities. Medivolve can leverage its expertise to introduce its products in these regions, capitalizing on the rising demand for medical supplies.
- Regulatory Approvals: Securing regulatory approvals for new products can open up additional revenue streams. Medivolve can focus on obtaining certifications for innovative medical instruments, allowing it to market its products in regions with stringent regulatory requirements.
What Threats Does MEDVD Face?
- Intense competition from established medical device companies.
- Regulatory hurdles can delay product launches.
- Economic downturns may impact healthcare spending.
What Are MEDVD's Competitive Advantages?
- Potential for high gross margins due to specialized products.
- Focus on innovation may lead to unique product offerings.
- Small size allows for agility in responding to market changes.
- Expertise in navigating regulatory environments could provide a competitive edge.
What Does MEDVD Do?
Medivolve Inc., headquartered in Toronto, US, is a healthcare company that specializes in medical instruments and supplies. The company has a workforce of 95 employees and has been positioned within the healthcare sector, which is characterized by rapid technological advancements and evolving patient needs. Founded with the vision of improving healthcare delivery through innovative solutions, Medivolve has aimed to address various challenges in the medical instruments market. However, detailed information about its founding story and product offerings remains limited, suggesting that the company may not have made significant public disclosures or advancements recently. The healthcare industry is known for its stringent regulations and competitive pressures, which Medivolve must navigate to establish a strong market presence. Despite the challenges, the company is poised to leverage its operational capabilities and expertise in medical supplies to adapt to changing market dynamics and fulfill the growing demand for healthcare solutions. As Medivolve continues to evolve, its ability to innovate and respond to market trends will be crucial for its future growth and sustainability.
What Products and Services Does MEDVD Offer?
- Develops and supplies medical instruments and healthcare solutions.
- Focuses on innovation to improve healthcare delivery.
- Operates within the medical instruments and supplies sector.
- Targets healthcare providers and institutions as primary customers.
- Strives to adapt to changing market demands and regulatory environments.
- Engages in research and development for new healthcare technologies.
How Does MEDVD Make Money?
- Generates revenue through the sale of medical instruments and supplies.
- Focuses on innovation to create differentiated products.
- Targets healthcare institutions and providers as key customers.
- May explore partnerships for co-development of healthcare solutions.
- Invests in research and development to enhance product offerings.
What Industry Does MEDVD Operate In?
The medical instruments and supplies industry is experiencing rapid growth, driven by technological advancements and an increasing focus on healthcare quality. Medivolve Inc. operates in a competitive landscape, facing challenges from established players and emerging startups. The demand for innovative medical solutions, particularly in response to the COVID-19 pandemic, has intensified competition, requiring companies like Medivolve to continually adapt and innovate to maintain market relevance. As healthcare providers increasingly seek advanced instruments and supplies, Medivolve's positioning within this industry will be crucial for its growth trajectory.
Who Are MEDVD's Key Customers?
- Healthcare providers including hospitals and clinics.
- Medical institutions requiring specialized instruments.
- Distributors of medical supplies and equipment.
- Government healthcare agencies.
- Private healthcare organizations.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 51 |
| 2026-08-24 | 51 |
| 2026-08-25 | 51 |
| 2026-08-26 | 51 |
What changed?
The score has stayed at 51.
Over the same 3 days the stock moved +0.0%.
Company Profile
Medivolve Inc operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Toronto, US. MEDVD has traded publicly since 2013.
Key Financial Metrics
Return on equity for Medivolve Inc stands at 213.2%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.08 means current liabilities exceed short-term assets, a liquidity point worth watching.
MEDVD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- High gross margin potential indicates efficient cost management.
- Small workforce allows for flexibility and rapid decision-making.
- Focus on healthcare innovation aligns with industry trends.
- Upcoming: Potential product launches that could enhance market presence.
Bear Case
- Significant negative profit margin presents financial challenges.
- Limited public information may raise investor concerns.
- Small size may limit market reach and scale.
- Potential: Regulatory challenges may delay product approvals.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
MEDVD Latest News
No recent news available for MEDVD.
MEDVD OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of the major exchanges like NYSE or NASDAQ. These companies may have less stringent reporting requirements, leading to less transparency and potentially higher risks for investors.
- OTC Tier: OTC Other
- Limited financial disclosures can lead to uncertainty about the company's performance.
- Lower liquidity may result in higher volatility in stock prices.
- Potential for fraud or misrepresentation is higher in OTC markets.
- Verify the company's financial health through available reports.
- Assess the management team's background and track record.
- Investigate the competitive landscape and market positioning.
- Review any recent news or developments related to the company.
- Evaluate the company's product pipeline and innovation strategy.
- Company's registration with relevant regulatory bodies.
- Presence of any partnerships or collaborations with reputable firms.
- Availability of third-party audits or reviews of financials.
Common Questions About MEDVD (Healthcare)
What happened to Medivolve Inc (MEDVD) stock?
Medivolve Inc (MEDVD) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy MEDVD shares?
No. MEDVD stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for MEDVD elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MEDVD stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Medivolve Inc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Medivolve Inc do?
Medivolve Inc. specializes in developing and supplying medical instruments and healthcare solutions. The company focuses on innovation to improve healthcare delivery and targets healthcare providers and institutions as its primary customers.
What do analysts say about MEDVD stock?
Currently, there is limited analyst coverage on Medivolve Inc. due to its status as an OTC stock and the lack of publicly available financial data. As such, there are no consensus ratings or price targets available.
What are the main risks for MEDVD?
Medivolve Inc. faces several risks, including regulatory challenges that may delay product approvals, which can impact its market entry and growth.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited public information and disclosures about the company's operations and financials.